SGK
BSX icon

Steigerwald Gordon & Koch’s Boston Scientific BSX Stock Holding History

Steigerwald Gordon & Koch’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.32K Hold
31
– – ﹤0.01% 714
2026
Q1 		$1.95K Sell
31
-199
-87% -$15.9K ﹤0.01% 692
2025
Q4 		$21.9K Buy
230
+199
+642% +$19.5K ﹤0.01% 437
2025
Q3 		$3.03K Buy
+31
New +$3.21K ﹤0.01% 693

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Steigerwald Gordon & Koch's BSX Position: Q2 2026 in Review

Steigerwald Gordon & Koch held its Boston Scientific (BSX) position steady in Q2 2026 at 31 shares worth $1.32K. The position accounts for ﹤0.01% of the portfolio, ranked #714.

Steigerwald Gordon & Koch first reported a position in BSX in Q3 2025 and has held it in 4 quarters since. The position peaked at $21.9K in Q4 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Steigerwald Gordon & Koch held 31 shares of Boston Scientific worth $1.32K as of Q2 2026.
  • Steigerwald Gordon & Koch left its Boston Scientific share count unchanged in Q2 2026.
  • Boston Scientific made up ﹤0.01% of Steigerwald Gordon & Koch's portfolio in Q2 2026, its #714 holding.
  • Steigerwald Gordon & Koch first reported a position in Boston Scientific in Q3 2025 and has held it in 4 quarters since.
  • Steigerwald Gordon & Koch's Boston Scientific position peaked at $21.9K in Q4 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Steigerwald Gordon & Koch's 13F filing for Q2 2026, filed 23 Jul 2026.